Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02142868
Title Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Recruitment No longer available
Gender female
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole + Palbociclib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.